REO VACCINE NOBILIS , STRAIN 1133

Description :
Live, freeze-dried vaccine containing10^3.1  TCID⁵⁰ per dose of the temperature sensitive, highly attenuated strain 133 of Reovirus. The vaccine pellet contains stabilizers and gentamicin has been added during the production process.

Indication :
The vaccine is intended for the prevention of Tenosynovitis (viral arthritis) in chickens of 7 days or older.

It is also intended for priming of breeder replacement stock.

Vaccination Programme :
Many factors must be considered in determining a sound vaccination programme for a particular farm. To be fully effective, the vaccine must be administered properly to healthy, receptive birds maintained in a proper environment under good management. In addition, the response may be influenced by the age of the birds and their immune status.

Protection against reoviruses involves the maternal transfer of antibody through the yolk to the progeny. To effect this transfer, an integrated programme using both inactivated and modified live virus vaccines is recommended.

In areas of high exposure, chicks can become susceptible during the first weeks of life. Therefore, early vaccination becomes mandatory. In these areas, vaccination could be accomplished beginning at day 7. Revaccination should be given at 5 to 7 weeks of age and again at 9 to 11 weeks.

In areas of lesser exposure, vaccination should be gven at 5 to 9 weeks of age and again at 9 to 11 weeks. To complete this programme for breeding birds, an inactivated reovirus vaccine is recommended at between 18 and 22 weeks.

Dosage and Administration :
Inject 0.2 ml of the reconstituted vaccine subcutaneously into the back of the neck.

Precautions and Warnings :
Do not vaccinate within 12 weeks prior to the onset and during egg production in breeders.

Presentation :
Vials containing 1000 doses of vaccine in boxes of 10 vials.
Diluent is supplied separately in bottles of 200 ml..